MYD88 and neoplasm: Despite the recognized importance of MyD88 signaling in driving high level IL-12 production in response to T. gondii infection [37], vaccination of MyD88-/- mice bearing ID8DV tumors provided a therapeutic benefit equivalent to vaccination of wild-type tumor-bearing mice (Fig 2B).